Structure Therapeutics Announces Closing of Upsized Public O

SAN FRANCISCO, June 07, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and

Related Keywords

New York , United States , Boston , Massachusetts , American , Danielle Keatley , Exchange Commission , Syndicate Department , Equity Syndicate Prospectus Department , Morgan Stanley , Goldman Sachs Co , Equity Syndicate Department , Morgan Stanley Co , Prospectus Department , Structure Therapeutics Inc , Capital Markets Corp , Guggenheim Securities , Structure Therapeutics , Leerink Partners , Markets Corp ,